Oncimmune (ONC.L): Positive Top Line Results for Early Cancer Detection Test | Verona Pharma (VRP.L): Commences Phase 2 study in COPD
04 Jun 2019
SPA Healthcare - Morning Comment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SPA Healthcare - Morning Comment
- Published:
04 Jun 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Oncimmune (ONC.L): Positive Top Line Results for Early Cancer Detection Test | Verona Pharma (VRP.L): Commences Phase 2 study in COPD